Loading company details...
Beta
Latest Form 4 (Sep 25, 2026): Keli Walbert (Director): Grant/Award of 36,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 25, 2026 | Keli Walbert | Grant/Award | 36,000 | n/a |
| Jun 17, 2026 | RA CAPITAL MANAGEMENT, L.P. | Purchase | 6,146 | $153.0K |
| May 21, 2026 | RA CAPITAL MANAGEMENT, L.P. | Purchase | 3,802 | $94.9K |
| May 14, 2026 | RA CAPITAL MANAGEMENT, L.P. | Purchase | 6,387 | $159.0K |
| May 11, 2026 | RA CAPITAL MANAGEMENT, L.P. | Purchase | 7,921 | $192.8K |
| May 6, 2026 | RA CAPITAL MANAGEMENT, L.P. | Conversion | 3,607,846 | n/a |
| May 6, 2026 | Novo Holdings A/S | Conversion | 4,180,550 | n/a |
| May 4, 2026 | John Maraganore | Conversion | 17,974 | n/a |
| May 4, 2026 | Catherine Madigan, Chief Medical Officer | Grant/Award | 145,134 | n/a |
| May 4, 2026 | Mads Nikolaj Behrndt-Eriksen, Chief Financial Officer and General Manager | Grant/Award | 195,206 | n/a |